GIP/GLP-1
Sort by:
ADA 2023 Insights
ADA 2023 Insights: Role for Amylin in Monotherapy and Combination Therapy for Obesity
FEATURING
David Lau
- 1,373 views
- July 14, 2023
- 11
Canadian Collaborative Research Network
Can Patients Living With Obesity Really Lose Weight and How Will They Benefit?
FEATURING
Sean Wharton
- 551 views
- July 26, 2023
- 7
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
FEATURING
Steven Nissen
- 5,636 views
- July 26, 2023
- 61
Practical Ways to Achieve Targets in Diabetes Care
Managing Obesity in Pediatrics
FEATURING
Tadej Battelino
- 593 views
- August 4, 2023
- 3
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
- 7,798 views
- August 14, 2023
- 114
Alyson Myers
Closing the Disparity Gaps in Diabetes Care - in the Bronx and Beyond
- 127 views
- August 18, 2023
- 2
Houston Methodist Hospital
Obesity: Epidemiology and Medical Management in 2023
FEATURING
Archana Sadhu
- 1,368 views
- August 22, 2023
- 6
Practical Ways to Achieve Targets in Diabetes Care
Diabetes Complications: Q&A / Panel Discussion
- 134 views
- August 23, 2023
- 2
Practical Ways to Achieve Targets in Diabetes Care
Cost Effectiveness of Newer Treatment Options for Type 2 Diabetes
FEATURING
Sandip Garg
- 552 views
- August 23, 2023
- 3
Practical Ways to Achieve Targets in Diabetes Care
Update on Diabetic Nephropathy & Retinopathy
FEATURING
John Buse
- 298 views
- August 23, 2023
- 3
Houston Methodist Hospital
Innovations in the Management of Obesity & Nonalcoholic Fatty Liver Disease Q&A and Discussion
FEATURING
Nabil Tariq,
Nadege Gunn
- 28 views
- August 27, 2023
Diana Isaacs
Clinical Pearls & Updates on Incretins: The Diabetes Drugs Taking Hollywood by Storm
- 3,387 views
- August 29, 2023
- 20
UT Health San Antonio School of Medicine
Effective Treatment of T2DM Requires Combination Therapy
FEATURING
Ralph DeFronzo
- 2,511 views
- August 30, 2023
- 20
Scripps Health
Primary Care Literature Update: 2022/2023
FEATURING
Joel Diamant
- 996 views
- September 12, 2023
- 18
Dr. Sharmila Ghimire
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
FEATURING
Dr. Sharmila Ghimire
- 182 views
- September 13, 2023
- 4
McMaster University Department of Medicine
Semaglutide: Where Are We Now and Where Are We Going?
- 4,169 views
- September 27, 2023
- 24
National Lipid Association
What’s New in Obesity Pharmacotherapy?
FEATURING
Harold Bays
- 758 views
- October 11, 2023
- 2
AHA 2023 Insights
AHA 2023 Insights: Optimizing the Use of SGLT2is, GLP-1 RAs and Non-Steroidal MRAs for Multi-System Benefit
FEATURING
Faiez Zannad
- 1,722 views
- November 21, 2023
- 19
Primary Care Education Consortium
Road Map & Speed Bumps in the Management of T2DM
FEATURING
Louis Kuritzky
- 241 views
- November 21, 2023
- 1
Primary Care Education Consortium
Cardiovascular and Kidney Outcomes With Glucose-Lowering Agents
FEATURING
James Gavin Iii
- 978 views
- November 21, 2023
- 8
Jefferson Health
Diabesity: New Trends in Management
FEATURING
Kevin Furlong
- 829 views
- November 23, 2023
- 11